Following Rejoni?
Get the free weekly funding digest
The latest funding rounds, like Rejoni’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New funding rounds, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Industry Trends
See who's moving and how much in your market
No credit card required Weekly funding digest
Rejoni, Inc. secures $25 million in financing to accelerate the Juveena Hydrogel System toward FDA approval and launch.
PRIVATEJun 16, 2026•7 days ago
Amount Raised
$25 Million
BedfordBiotechnologyInvestors
Sparta GroupIyengar CapitalFem Health VenturesDelos CapitalCatalyst Health VenturesAscension VenturesAmed VenturesClavyst Bio
Description
Rejoni, Inc., a clinical-stage company in Bedford, MA, has closed $25 million in financing with support from new and existing investors. The funds will help build the foundation for Juveena, designed to support endometrial healing. The company aims to prepare for commercial launch once approved by the U.S. FDA
Related People
Suggested for you
4 contacts2 more contacts · See plans
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching Rejoni? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan